March 03, 2015 8:50 AM ET

Healthcare Equipment and Supplies

Company Overview of Conceptus, Inc.

Company Overview

Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and Europe. It primarily provides Essure system, a permanent birth control system that delivers an insert into a woman’s fallopian tubes. The company sells its products through direct sales force and distribution networks to physicians and hospitals. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California. As of June 5, 2013, Conceptus, Inc. operates as a subsidiary of Bayer HealthCare, LLC.

331 East Evelyn Avenue

Mountain View, CA 94041

United States

Founded in 1992

286 Employees





Key Executives for Conceptus, Inc.

Executive Vice President of Operations
Chief Compliance Officer, Executive Vice President, General Counsel and Secretary
Age: 68
Executive Vice President of Research and Development
Age: 50
Executive Vice President of Human Resources
Vice President of Strategic & Professional Marketing
Compensation as of Fiscal Year 2014.

Conceptus, Inc. Key Developments

Conceptus, Inc. Announces Board Resignations

On April 28, 2013, Conceptus, Inc. entered into an agreement and plan of merger with Bayer HealthCare LLC and Evelyn Acquisition Company. In accordance with the merger agreement, each of Kathryn A. Tunstall, D. Keith Grossman, Thomas F. Bonadio and Robert V. Toni resigned from the board of directors of the company and from all committees of the board on which such directors served, effective as of the acceptance time on June 5, 2013, subject to payment for the shares tendered into the offer.

Conceptus, Inc.(NasdaqGM:CPTS) dropped from NASDAQ Composite Index

Conceptus, Inc. will be removed from NASDAQ Composite Index.

Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty and Other Violations of State Law Against the Board of Conceptus, Inc

Levi & Korsinsky notifies investors of Conceptus, Inc. of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the company in connection with the sale of the company to Bayer HealthCare LLC. A complaint was filed in California state court. Under the terms of the transaction, Conceptus shareholders will receive $31.00 for each share of Conceptus stock they own. The claims concern whether the Conceptus Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the company before agreeing to enter into the transaction, and whether Bayer HealthCare LLC is underpaying for Conceptus stock, thus unlawfully harming Conceptus stockholders.

Similar Private Companies By Industry

Company Name Region
BOSS Instruments, Ltd. United States
Surgilight, Inc. United States
Veritract, Inc. United States
Augmenix, Inc. United States
Cobra Stylet L.L.C. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Conceptus, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at